IX The International Seminar on the Immunological System as a Target for Toxic Damage was held at The Commission of the European Communities (CEC) in Luxembourg on 6-9 November 1984.
The dramatic improvement made in recent years in the treatment of child- hood malignancies has been in large part the result of advances in the field of pharmacology.
Since insulin became available for the treatment of diabetes in 1922 a number of major advances have been made, which include the modification of insulin to vary its timing of action, its purification, and latterly, the production of human insulin.
Public health and antiseptic measures, vaccination and antibiotics, have all contributed to the reduction in the incidence and impact of diseases due to infections in younger age groups.
This volume contains papers presented at the NATO Advanced Research Workshop on the Structure and Dynamics of Partially Solidified Systems held at Stanford Sierra Lodge, Tahoe, California, May 12-16, 1986.
The International Meeting on Brain Oncology in Rennes was organised in honor of Jean Pecker, to pay tribute to his contribution to the development of neurological sciences and to take stock of the current state of knowledge on brain tumors, a domain in which the role of neurosurgery has been and will continue to be primordial.
The development of monoclonal antibodies to human tumor associated antigens has greatly facilitated the application of immunohistochemical techniques to analyze surgically removed tissues.
The last 30 years have seen little improvement in the age-adjusted mortality rates for most common types of cancer, and until we develop more effective and less damaging treatment modalities for these tumours, selection of each patient's treatment must depend on prognostic pointers.
Previous volumes in this series have discussed the current progression have identified a variety of targets and strategies state of our knowledge concerning the pathophysiology of to allow these goals to be realized.
This volume emphasizes metastasis/dissemination as im- nective tissues, muscle, tumours of neuronal origins and portant processes in cancer growth and progression.
This volume reviews our current knowledge concerning can- Several chapters discuss the contributions of genetic asp- cer growth and progression as it relates to the etiology of ects, metabolism, endocrine-related aspects and nutrition to human cancer.
It is widely recognized that the host response to tumor munotherapy of experimental metastases in animal systems progression is an important determinant in cancer growth which are beginning to be developed for ultimate clinical and progression.
Recent experimental evidence has made it increasingly clear In particular, this volume reviews the discrete steps involved that the properties of invasive, malignant cells during tumor in metastatic invasion: the interaction of invasive tumor cells development substantially impact on the host.
Despite the fact that the incidence of gastric cancer is declining in the Western world, it remains a significant problem with respect to accurate diagnosis and treatment since it has a high mortality rate.
This book is a direct result of a symposium held in December 1988, in Washington, DC, honoring Professor Emeritus Miodrag Ristic for his contributions to rickettsial disease research, in general, and, to ehrlichiosis, in particular.
Immunotherapy began in 1774 when the Dorset farmer Benjamin Jesty inoculated his wife and two sons with the pus from the teat of a cow suffering from cow pox, using his wife's knitting needle as a vaccinating implement.
Despite enormous efforts, over 100,000 papers and over $22 billion spent by the US taxpayer alone, the HIV-AIDS hypothesis has failed to produce any public health benefits, no vaccine, no effective drug, no prevention, no cure, not a single life saved.
